The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the legs. These blockages, called chronic total occlusions (CTOs), are often associated with peripheral artery disease (PAD). The data from the Re-ROUTE clinical trial were reported in a late-breaking clinical trial session at the Vascular Interventional Advances Conference (VIVA) in Las Vegas.

CardioDx Inc. announced results of two studies indicating that Corus CAD, a blood-based gene expression test, may help reduce unnecessary cardiac testing and costs by aiding clinician decision-making in the evaluation of women with obstructive coronary artery disease (CAD) symptoms. The studies were presented at The North American Menopause Society (NAMS) 2013 Annual Meeting in Dallas, Texas.

Preventice Inc. has received CE mark certification for its BodyGuardian remote monitoring system.

Critical Diagnostics announced that results of the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise (HF-Action) study published in the American Heart Association’s (AHA’s) Circulation: Heart Failure demonstrates that levels of the biomarker ST2 are predictive of long-term outcomes for people suffering with heart failure and identify those patients who may benefit from exercise.

At RSNA 2013, ContextVision will announce its latest additions to its U.S. PlusView Family, which will include four different packages for women’s health, general imaging, cardiovascular and point of care (POC). More anatomically correct images provide medical professionals diagnostic confidence for the most complex patient cases.